Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SB 277011

Known as: SB 277011-A, SB-277011, SB-277011-A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
The dopamine D3 receptor (DRD3) has been suggested to be involved in the mechanisms underlying stimulus-controlled drug-seeking… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Examination of dopamine-D3 (D3) receptors with positron emission tomography (PET) have been hampered in the past by the lack of a… Expand
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The mesolimbic dopamine (DA) system plays an important role in mediating addiction to alcohol and other drugs of abuse. Recent… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Dopamine (DA) receptors are a major target for drugs employed in the treatment of neuropsychiatric disorders such as… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Conditioned stimuli (CS) previously paired with drugs of abuse can elicit cravings in humans, relapse to drug use, and can also… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The dopamine D3 receptor is preferentially localized to the mesocorticolimbic dopaminergic system and has been hypothesized to… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2001
2001
1. In vitro studies with the selective dopamine D3 receptor antagonist SB-277011 were conducted in liver microsomes and… Expand
Is this relevant?
Review
2001
Review
2001
It is presumed that GlaxoSmithKline has taken over from SmithKline Beecham in investigating the highly selective dopamine D3… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
SB-277011-A (trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolininecarboxamide), is a brain… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A selective dopamine D(3) receptor antagonist offers the potential for an effective antipsychotic therapy, free of the serious… Expand
Is this relevant?